Tigulixostat 200 mg Placebo Tablet clinical trials

A Randomized, Multi-regional, Double-blind, Double-dummy Parallel-group, Placebo and Allopurinol-controlled Phase 3 Study to Assess the Efficacy and Safety of Tigulixostat in Gout Patients with Hyperuricemia

This study is testing a new medicine, Tigulixostat, for people with gout and high uric acid. Researchers want to see if it lowers uric acid levels as well as current treatments and if it's safe to use. It compares Tigulixostat to a common gout medicine, Allopurinol, and a dummy pill.